| Term | Count | % | | DRUG INEFFECTIVE | 4105 | 9.00% |
| TREATMENT FAILURE | 3079 | 6.75% |
| OCULAR HYPERAEMIA | 2350 | 5.15% |
| EYE IRRITATION | 1861 | 4.08% |
| MADAROSIS | 1393 | 3.06% |
| EYE PRURITUS | 1334 | 2.93% |
| ERYTHEMA OF EYELID | 1014 | 2.22% |
| EYE PAIN | 954 | 2.09% |
| HYPERSENSITIVITY | 854 | 1.87% |
| VISION BLURRED | 846 | 1.86% |
| OFF LABEL USE | 730 | 1.60% |
| INTRAOCULAR PRESSURE INCREASED | 724 | 1.59% |
| FATIGUE | 721 | 1.58% |
| HEADACHE | 688 | 1.51% |
| DRY EYE | 657 | 1.44% |
| EYE SWELLING | 653 | 1.43% |
| WRONG TECHNIQUE IN PRODUCT USAGE PROCESS | 586 | 1.29% |
| DYSPNOEA | 554 | 1.22% |
| INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION | 539 | 1.18% |
| DIZZINESS | 535 | 1.17% |
| EYELIDS PRURITUS | 530 | 1.16% |
| NAUSEA | 522 | 1.14% |
| ERYTHEMA | 518 | 1.14% |
| DIARRHOEA | 513 | 1.13% |
| INCORRECT DOSE ADMINISTERED | 500 | 1.10% |
| SKIN HYPERPIGMENTATION | 481 | 1.05% |
| FALL | 479 | 1.05% |
| VISUAL IMPAIRMENT | 468 | 1.03% |
| ASTHENIA | 453 | 0.99% |
| PRURITUS | 434 | 0.95% |
| EYELID OEDEMA | 419 | 0.92% |
| PAIN | 405 | 0.89% |
| WRONG TECHNIQUE IN DRUG USAGE PROCESS | 404 | 0.89% |
| DEATH | 397 | 0.87% |
| EYELID IRRITATION | 376 | 0.82% |
| LACRIMATION INCREASED | 376 | 0.82% |
| PRODUCT DOSE OMISSION ISSUE | 375 | 0.82% |
| RASH | 361 | 0.79% |
| CATARACT | 348 | 0.76% |
| INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION | 338 | 0.74% |
| GLAUCOMA | 336 | 0.74% |
| MALAISE | 328 | 0.72% |
| EYE DISCHARGE | 306 | 0.67% |
| THERAPEUTIC RESPONSE DECREASED | 301 | 0.66% |
| GROWTH OF EYELASHES | 297 | 0.65% |
| PNEUMONIA | 293 | 0.64% |
| SKIN DISCOLOURATION | 293 | 0.64% |
| ARTHRALGIA | 286 | 0.63% |
| VISUAL ACUITY REDUCED | 285 | 0.63% |
| TRICHORRHEXIS | 281 | 0.62% |
| BLEPHARAL PIGMENTATION | 279 | 0.61% |
| VOMITING | 276 | 0.61% |
| COUGH | 273 | 0.60% |
| DRUG DOSE OMISSION | 272 | 0.60% |
| PAIN IN EXTREMITY | 272 | 0.60% |
| WEIGHT DECREASED | 269 | 0.59% |
| DRUG HYPERSENSITIVITY | 266 | 0.58% |
| ACCIDENTAL EXPOSURE TO PRODUCT | 254 | 0.56% |
| INSOMNIA | 250 | 0.55% |
| PRODUCT QUALITY ISSUE | 250 | 0.55% |
| HYPERTENSION | 241 | 0.53% |
| EYE DISORDER | 227 | 0.50% |
| FOREIGN BODY SENSATION IN EYES | 215 | 0.47% |
| NO ADVERSE EVENT | 213 | 0.47% |
| CONSTIPATION | 208 | 0.46% |
| DECREASED APPETITE | 208 | 0.46% |
| BLOOD PRESSURE INCREASED | 207 | 0.45% |
| PRODUCT PACKAGING QUANTITY ISSUE | 205 | 0.45% |
| BACK PAIN | 200 | 0.44% |
| OCULAR DISCOMFORT | 200 | 0.44% |
| GAIT DISTURBANCE | 195 | 0.43% |
| ANXIETY | 193 | 0.42% |
| ANAEMIA | 191 | 0.42% |
| CONDITION AGGRAVATED | 191 | 0.42% |
| HYPOTENSION | 191 | 0.42% |
| HAIR GROWTH ABNORMAL | 188 | 0.41% |
| URINARY TRACT INFECTION | 184 | 0.40% |
| PYREXIA | 179 | 0.39% |
| PHOTOPHOBIA | 175 | 0.38% |
| FEELING ABNORMAL | 172 | 0.38% |
| BLINDNESS | 168 | 0.37% |
| DEPRESSION | 162 | 0.36% |
| PERIPHERAL SWELLING | 162 | 0.36% |
| CONFUSIONAL STATE | 161 | 0.35% |
| SWELLING OF EYELID | 160 | 0.35% |
| SOMNOLENCE | 159 | 0.35% |
| MYALGIA | 157 | 0.34% |
| EXPIRED PRODUCT ADMINISTERED | 155 | 0.34% |
| ABDOMINAL DISCOMFORT | 154 | 0.34% |
| ATRIAL FIBRILLATION | 152 | 0.33% |
| NASOPHARYNGITIS | 152 | 0.33% |
| CHEST PAIN | 151 | 0.33% |
| CEREBROVASCULAR ACCIDENT | 149 | 0.33% |
| ACUTE KIDNEY INJURY | 148 | 0.32% |
| DRUG ADMINISTERED AT INAPPROPRIATE SITE | 148 | 0.32% |
| EYELID PAIN | 148 | 0.32% |
| OEDEMA PERIPHERAL | 148 | 0.32% |
| WEIGHT INCREASED | 146 | 0.32% |
| ALOPECIA | 145 | 0.32% |
| BLOOD GLUCOSE INCREASED | 145 | 0.32% |
| Total | 45594 | |